AstraZeneca's severe asthma treatment approved in EU for self-administration - PMLiVE

Retrieved on: 2023-01-13 12:58:08

Tags for this article:

Health

Medical specialties

Asthma

Respiratory therapy

Monoclonal antibodies

Clinical trial

Reslizumab

AstraZeneca

Click the tags to see associated articles and topics

AstraZeneca's severe asthma treatment approved in EU for self-administration - PMLiVE. View article details on HISWAI: https://www.pmlive.com/pharma_news/astrazenecas_severe_asthma_treatment_approved_in_eu_for_self-administration_1485311

Excerpt

AstraZeneca's Tezspire (tezepelumab) has been approved for self-administration in patients with severe asthma aged 12 years and older after it ...

Article found on: www.pmlive.com

View Original Article